268 (Carbamazepine 200 mg)

Pill imprint 268 has been identified as Carbamazepine 200 mg.

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; epilepsy; schizoaffective disorder; diabetic peripheral neuropathy (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 268

Carbamazepine 200 mg 268
Carbamazepine
Imprint:
268
Strength:
200 mg
Color:
Pink
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Torrent Pharmaceuticals
National Drug Code (NDC):
13668-0268
Inactive Ingredients:
silicon dioxide colloidal
FD&C Red No. 40
hypromelloses
magnesium stearate
sodium starch glycolate type A potato
pregelatinized corn starch

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)